Nitric oxide inhibition ameliorates cortical proteomic changes in the Cntnap2<sup>-/-</sup> and Shank3<sup>Δ4-22</sup> mouse models of autism spectrum disorder.

Mol Autism · 2026 · PMC13107916 · PMID 42010670

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

7 C and D); however, the WB differences did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Nitric oxide inhibition ameliorates cortical proteomic changes in the Cntnap2&lt;sup&gt;-/-&lt;/sup&gt; and Shank3&lt;sup&gt;Δ4-22&lt;/sup&gt; mouse models of autism spectrum disorder.

The sentences

Nitric oxide inhibition ameliorates cortical proteomic changes in the Cntnap2<sup>-/-</sup> and Shank3<sup>Δ4-22</sup> mouse models of autism spectrum disorder.